Skip to main content
Top
Published in: Diabetologia 11/2009

01-11-2009 | Article

Improvement of left ventricular function by lifestyle intervention in obesity: contributions of weight loss and reduced insulin resistance

Authors: W. Kosmala, T. O’Moore-Sullivan, R. Plaksej, M. Przewlocka-Kosmala, T. H. Marwick

Published in: Diabetologia | Issue 11/2009

Login to get access

Abstract

Aims/hypothesis

Weight excess and insulin resistance mediate the link between obesity and left ventricular dysfunction. We investigated the effect and mechanisms of lifestyle modification on left ventricular function changes in obese patients.

Methods

Reduction of body weight and insulin resistance was sought using a behavioural intervention programme including dietary restrictions and exercise training in 261 patients (age 45 ± 13 years) with BMI ≥30 kg/m2, no history of cardiac disease and a normal stress echocardiogram. Each patient underwent echocardiographic measurement of myocardial deformation and velocity at baseline and at 6 month follow-up.

Results

Improvements in left ventricular systolic and diastolic function were demonstrated only in patients with significant reduction of weight and/or insulin resistance. Left ventricular improvement was less frequent in patients with diabetes than in those without (52% vs 82% for strain, 50% vs 81% for strain rate and 59% vs 80% for peak early diastolic myocardial velocity). The independent predictors of improved left ventricular systolic function (increase in strain) were: weight reduction (β = 0.14, p < 0.05), decrease in the HOMA insulin resistance index (β = 0.20, p < 0.005) and absence of diabetes (β = 0.18, p < 0.02). A decrease in HbA1c also predicted improvement of left ventricular diastolic function (β = 0.26, p < 0.001). There was a parallel increment in exercise capacity with intervention and increase in strain was independently correlated with increase in \( \dot{V}{\text{O}}_2 \) (β = 0.13, p < 0.04).

Conclusions/interpretation

Effective lifestyle modifications in obese patients improve left ventricular systolic and diastolic function, but appear less effective with co-existing diabetes. The reversal of left ventricular function abnormalities is associated with reduction of both weight and insulin resistance, and is accompanied by an increase in cardiorespiratory fitness.
Literature
1.
go back to reference Murphy NF, MacIntyre K, Stewart S, Hart CL, Hole D, McMurray JJ (2006) Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15 000 middle-aged men and women (the Renfrew–Paisley study). Eur Heart J 27:96–106CrossRefPubMed Murphy NF, MacIntyre K, Stewart S, Hart CL, Hole D, McMurray JJ (2006) Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15 000 middle-aged men and women (the Renfrew–Paisley study). Eur Heart J 27:96–106CrossRefPubMed
3.
go back to reference Kenchaiah S, Evans JC, Levy D et al (2002) Obesity and the risk of heart failure. N Engl J Med 347:305–313CrossRefPubMed Kenchaiah S, Evans JC, Levy D et al (2002) Obesity and the risk of heart failure. N Engl J Med 347:305–313CrossRefPubMed
4.
go back to reference Di Bello V, Santini F, Di Cori A et al (2006) Relationship between preclinical abnormalities of global and regional left ventricular function and insulin resistance in severe obesity. Int J Obes (Lond) 30:948–956CrossRef Di Bello V, Santini F, Di Cori A et al (2006) Relationship between preclinical abnormalities of global and regional left ventricular function and insulin resistance in severe obesity. Int J Obes (Lond) 30:948–956CrossRef
5.
go back to reference Wong CY, O’Moore-Sullivan T, Leano R, Byrne N, Beller E, Marwick TH (2004) Alterations of left ventricular myocardial characteristics associated with obesity. Circulation 110:3081–3087CrossRefPubMed Wong CY, O’Moore-Sullivan T, Leano R, Byrne N, Beller E, Marwick TH (2004) Alterations of left ventricular myocardial characteristics associated with obesity. Circulation 110:3081–3087CrossRefPubMed
6.
go back to reference Ingelsson E, Sundstrom J, Arnlov J, Zethelius B, Lind L (2005) Insulin resistance and risk of congestive heart failure. JAMA 294:334–341CrossRefPubMed Ingelsson E, Sundstrom J, Arnlov J, Zethelius B, Lind L (2005) Insulin resistance and risk of congestive heart failure. JAMA 294:334–341CrossRefPubMed
7.
go back to reference Alpert MA, Lambert CR, Panayiotou H et al (1995) Relation of duration of morbid obesity to left ventricular mass, systolic function, and diastolic filling, and effect of weight loss. Am J Cardiol 76:1194–1197CrossRefPubMed Alpert MA, Lambert CR, Panayiotou H et al (1995) Relation of duration of morbid obesity to left ventricular mass, systolic function, and diastolic filling, and effect of weight loss. Am J Cardiol 76:1194–1197CrossRefPubMed
8.
go back to reference Alpert MA, Lambert CR, Terry BE et al (1995) Effect of weight loss on left ventricular diastolic filling in morbid obesity. Am J Cardiol 76:1198–1201CrossRefPubMed Alpert MA, Lambert CR, Terry BE et al (1995) Effect of weight loss on left ventricular diastolic filling in morbid obesity. Am J Cardiol 76:1198–1201CrossRefPubMed
9.
go back to reference Ikonomidis I, Mazarakis A, Papadopoulos C et al (2007) Weight loss after bariatric surgery improves aortic elastic properties and left ventricular function in individuals with morbid obesity: a 3-year follow-up study. J Hypertens 25:439–447CrossRefPubMed Ikonomidis I, Mazarakis A, Papadopoulos C et al (2007) Weight loss after bariatric surgery improves aortic elastic properties and left ventricular function in individuals with morbid obesity: a 3-year follow-up study. J Hypertens 25:439–447CrossRefPubMed
10.
go back to reference Alpert MA, Terry BE, Mulekar M et al (1997) Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss. Am J Cardiol 80:736–740CrossRefPubMed Alpert MA, Terry BE, Mulekar M et al (1997) Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss. Am J Cardiol 80:736–740CrossRefPubMed
11.
go back to reference Look AHEAD Research Group (2007) Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the Look AHEAD trial. Diabetes Care 30:1374–1383CrossRef Look AHEAD Research Group (2007) Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the Look AHEAD trial. Diabetes Care 30:1374–1383CrossRef
12.
go back to reference Pi-Sunyer FX, Aronne LJ, Heshmati HM, Devin J, Rosenstock J, RIO-North America Study Group (2006) Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients. JAMA 295:761–775CrossRefPubMed Pi-Sunyer FX, Aronne LJ, Heshmati HM, Devin J, Rosenstock J, RIO-North America Study Group (2006) Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients. JAMA 295:761–775CrossRefPubMed
13.
go back to reference Kosmala W, Wong C, Kuliczkowska J, Leano R, Przewlocka-Kosmala M, Marwick TH (2008) Use of body weight and insulin resistance to select obese patients for echocardiographic assessment of subclinical left ventricular dysfunction. Am J Cardiol 101:1334–1340CrossRefPubMed Kosmala W, Wong C, Kuliczkowska J, Leano R, Przewlocka-Kosmala M, Marwick TH (2008) Use of body weight and insulin resistance to select obese patients for echocardiographic assessment of subclinical left ventricular dysfunction. Am J Cardiol 101:1334–1340CrossRefPubMed
14.
go back to reference American Diabetes Association (2008) Diagnosis and classification of diabetes mellitus. Diabetes Care 31(Suppl. 1):S55–S60CrossRef American Diabetes Association (2008) Diagnosis and classification of diabetes mellitus. Diabetes Care 31(Suppl. 1):S55–S60CrossRef
15.
go back to reference Alberti KG, Zimmet P, Shaw J (2006) Metabolic syndrome—a new world-wide definition. Diabet Med 23:469–480CrossRefPubMed Alberti KG, Zimmet P, Shaw J (2006) Metabolic syndrome—a new world-wide definition. Diabet Med 23:469–480CrossRefPubMed
16.
go back to reference Anderson KM, Wilson PWF, Odell PM, Kannel WB (1991) An updated coronary risk profile. Circulation 83:356–362PubMed Anderson KM, Wilson PWF, Odell PM, Kannel WB (1991) An updated coronary risk profile. Circulation 83:356–362PubMed
17.
go back to reference Pate RR, Pratt M, Blair SN, Haskell WL, Macera CA, Bouchard C (1995) Physical activity and public health. JAMA 273:402–407CrossRefPubMed Pate RR, Pratt M, Blair SN, Haskell WL, Macera CA, Bouchard C (1995) Physical activity and public health. JAMA 273:402–407CrossRefPubMed
18.
go back to reference Jakicic JM (2003) Exercise in the treatment of obesity. Endocrinol Metab Clin North Am 32:967–980CrossRefPubMed Jakicic JM (2003) Exercise in the treatment of obesity. Endocrinol Metab Clin North Am 32:967–980CrossRefPubMed
19.
go back to reference Yokoyama H, Emoto M, Fujiwara S et al (2003) Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment in normal range weight and moderately obese type 2 diabetic patients. Diabetes Care 26:2426–2432CrossRefPubMed Yokoyama H, Emoto M, Fujiwara S et al (2003) Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment in normal range weight and moderately obese type 2 diabetic patients. Diabetes Care 26:2426–2432CrossRefPubMed
20.
go back to reference Lang RM, Bierig M, Devereux RB, Chamber Quantification Writing Group, American Society of Echocardiography’s Guidelines and Standards Committee, European Association of Echocardiography et al (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography. J Am Soc Echocardiogr 18:1440–1463CrossRefPubMed Lang RM, Bierig M, Devereux RB, Chamber Quantification Writing Group, American Society of Echocardiography’s Guidelines and Standards Committee, European Association of Echocardiography et al (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography. J Am Soc Echocardiogr 18:1440–1463CrossRefPubMed
21.
go back to reference De Simone G, Devereux RB, Roman MJ, Alderman MH, Laragh JH (1994) Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension 23:600–606PubMed De Simone G, Devereux RB, Roman MJ, Alderman MH, Laragh JH (1994) Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension 23:600–606PubMed
22.
go back to reference Ommen SR, Nishimura RA, Appleton CP et al (2000) Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation 102:1788–1794PubMed Ommen SR, Nishimura RA, Appleton CP et al (2000) Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation 102:1788–1794PubMed
23.
go back to reference Hanley JA, McNeil BJ (1983) A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148:839–843PubMed Hanley JA, McNeil BJ (1983) A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148:839–843PubMed
24.
go back to reference Peterson LR, Herrero P, Schechtman KB et al (2004) Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation 109:2191–2196CrossRefPubMed Peterson LR, Herrero P, Schechtman KB et al (2004) Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation 109:2191–2196CrossRefPubMed
25.
go back to reference Wong CY, Byrne NM, O’Moore-Sullivan T, Hills AP, Prins JB, Marwick TH (2006) Effect of weight loss due to lifestyle intervention on subclinical cardiovascular dysfunction in obesity (body mass index > 30 kg/m2). Am J Cardiol 98:1593–1598CrossRefPubMed Wong CY, Byrne NM, O’Moore-Sullivan T, Hills AP, Prins JB, Marwick TH (2006) Effect of weight loss due to lifestyle intervention on subclinical cardiovascular dysfunction in obesity (body mass index > 30 kg/m2). Am J Cardiol 98:1593–1598CrossRefPubMed
26.
go back to reference Verreth W, de Keyzer D, Pelat M et al (2004) Weight loss-associated induction of peroxisome proliferator-activated receptor-α and peroxisome proliferator-activated receptor-γ correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice. Circulation 110:3259–3269CrossRefPubMed Verreth W, de Keyzer D, Pelat M et al (2004) Weight loss-associated induction of peroxisome proliferator-activated receptor-α and peroxisome proliferator-activated receptor-γ correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice. Circulation 110:3259–3269CrossRefPubMed
27.
go back to reference Shinmura K, Tamaki K, Saito K, Nakano Y, Tobe T, Bolli R (2007) Cardioprotective effects of short-term caloric restriction are mediated by adiponectin via activation of AMP-activated protein kinase. Circulation 116:2809–2817CrossRefPubMed Shinmura K, Tamaki K, Saito K, Nakano Y, Tobe T, Bolli R (2007) Cardioprotective effects of short-term caloric restriction are mediated by adiponectin via activation of AMP-activated protein kinase. Circulation 116:2809–2817CrossRefPubMed
28.
go back to reference Hawley JA, Lessard SJ (2008) Exercise training-induced improvements in insulin action. Acta Physiol 192:127–135CrossRef Hawley JA, Lessard SJ (2008) Exercise training-induced improvements in insulin action. Acta Physiol 192:127–135CrossRef
29.
go back to reference Freeman GL, Harris MM, Ghidoni JJ, Page A, Cantu TL, Young E (1994) Analysis of myocardial response to significant weight loss in obese rats. Am J Clin Nutr 59:566–571PubMed Freeman GL, Harris MM, Ghidoni JJ, Page A, Cantu TL, Young E (1994) Analysis of myocardial response to significant weight loss in obese rats. Am J Clin Nutr 59:566–571PubMed
30.
go back to reference Riordan MM, Weiss EP, Meyer TE et al (2008) The effects of caloric restriction- and exercise-induced weight loss on left ventricular diastolic function. Am J Physiol Heart Circ Physiol 294:H1174–H1182CrossRefPubMed Riordan MM, Weiss EP, Meyer TE et al (2008) The effects of caloric restriction- and exercise-induced weight loss on left ventricular diastolic function. Am J Physiol Heart Circ Physiol 294:H1174–H1182CrossRefPubMed
31.
go back to reference Karason K, Wallentin I, Larsson B, Sjöström L (1998) Effects of obesity and weight loss on cardiac function and valvular performance. Obes Res 6:422–429PubMed Karason K, Wallentin I, Larsson B, Sjöström L (1998) Effects of obesity and weight loss on cardiac function and valvular performance. Obes Res 6:422–429PubMed
32.
go back to reference Ippisch HM, Inge TH, Daniels SR et al (2008) Reversibility of cardiac abnormalities in morbidly obese adolescents. J Am Coll Cardiol 51:1342–1348CrossRefPubMed Ippisch HM, Inge TH, Daniels SR et al (2008) Reversibility of cardiac abnormalities in morbidly obese adolescents. J Am Coll Cardiol 51:1342–1348CrossRefPubMed
33.
go back to reference Dayi SU, Kasikcioglu H, Uslu N et al (2006) Influence of weight loss on myocardial performance index. Heart Vessels 21:84–88CrossRefPubMed Dayi SU, Kasikcioglu H, Uslu N et al (2006) Influence of weight loss on myocardial performance index. Heart Vessels 21:84–88CrossRefPubMed
34.
go back to reference Willens HJ, Chakko SC, Byers P et al (2005) Effect of weight loss after gastric bypass on right and left ventricular function assessed by tissue Doppler imaging. Am J Cardiol 95:1521–1524CrossRefPubMed Willens HJ, Chakko SC, Byers P et al (2005) Effect of weight loss after gastric bypass on right and left ventricular function assessed by tissue Doppler imaging. Am J Cardiol 95:1521–1524CrossRefPubMed
35.
go back to reference Karason K, Wallentin I, Larsson B, Sjostrom L (1997) Effect of obesity and weight loss on left ventricular mass and relative wall thickness: survey and intervention study. BMJ 315:912–916PubMed Karason K, Wallentin I, Larsson B, Sjostrom L (1997) Effect of obesity and weight loss on left ventricular mass and relative wall thickness: survey and intervention study. BMJ 315:912–916PubMed
36.
go back to reference Gondoni LA, Titon AM, Silvestri G et al (2007) Short term effects of physical exercise and low calorie diet on left ventricular function in obese subjects: a tissue Doppler study. Nutr Metab Cardiovasc Dis 17:358–364CrossRefPubMed Gondoni LA, Titon AM, Silvestri G et al (2007) Short term effects of physical exercise and low calorie diet on left ventricular function in obese subjects: a tissue Doppler study. Nutr Metab Cardiovasc Dis 17:358–364CrossRefPubMed
37.
go back to reference Ziccardi P, Nappo F, Giugliano G et al (2002) Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 105:804–809CrossRefPubMed Ziccardi P, Nappo F, Giugliano G et al (2002) Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 105:804–809CrossRefPubMed
Metadata
Title
Improvement of left ventricular function by lifestyle intervention in obesity: contributions of weight loss and reduced insulin resistance
Authors
W. Kosmala
T. O’Moore-Sullivan
R. Plaksej
M. Przewlocka-Kosmala
T. H. Marwick
Publication date
01-11-2009
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 11/2009
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-009-1507-4

Other articles of this Issue 11/2009

Diabetologia 11/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.